Status:
RECRUITING
Study on Sex-specific, Individualized Dose Calculation of Contrast Agent in CT Examinations
Lead Sponsor:
University Hospital Augsburg
Conditions:
CT Scans
Contrast Media
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A large proportion of radiological CT examinations require the intravenous administration of iodine-containing X-ray contrast medium. According to current guidelines, the amount required for CT examin...
Eligibility Criteria
Inclusion
- Presence of a justifying indication for a CT scan of the thorax and abdomen with application of intravenous contrast medium and a start delay corresponding to the portal venous contrast medium phase
- Ability to give informed consent, as well as written and verbal consent to participate in the study available
Exclusion
- Cardiorespiratory instability (as assessed by the attending physician)
- Age \<18 years
- Existing or suspected pregnancy
- Known post hepatectomy and/or splenectomy
- Lack of current height (in the same inpatient/outpatient hospital stay) or lack of possibility of height measurement
- Lack of current daily body weight or inability to measure body weight
- Height under 140 cm or over 220 cm
- Body weight under 50 kg or over 120 kg
- Contraindication to iodine-containing contrast medium (Allergy to contrast media containing iodine, Severe renal insufficiency (eGFR \< 30 ml/min), Hyperthyroidism)
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06965790
Start Date
April 1 2025
End Date
March 1 2027
Last Update
December 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hosptial Augsburg
Augsburg, Bavaria, Germany, 86157